MASP1 as a favorable prognostic biomarker in pediatric osteosarcoma: an integrated analysis of machine learning, bioinformatics, and validation experiments
<i>MASP1</i> is a promising diagnostic biomarker and therapeutic target for OS. These findings could help to improve patient prognosis and the treatment response. Further studies should be conducted explore <i>MASP1</i> clinical applications.
Authors
- Serenus Hua
- Tomoki Nakamura (ORCID: https://orcid.org/0000-0002-1099-7436)
- Junxuan Lü (ORCID: https://orcid.org/0000-0002-2354-7186)
- Cheng-Kua Huang
- Chao Lü (ORCID: https://orcid.org/0000-0002-9469-6672)
- Shou-Wen Tao
- Zhen Long (ORCID: https://orcid.org/0000-0002-1772-916X)
- Da Fang
Institutions
- Mie University (JP)
- Affiliated Hospital of Youjiang Medical University for Nationalities (CN)
- Baise University (CN)
Publication Details
- Journal
- Translational Pediatrics
- Published
- 2025-05-01
- DOI
- https://doi.org/10.21037/tp-2025-262
- Citations
- 1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81